10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,727,865 | +53.0% | 405,524 | +107.1% | 0.05% | +52.9% |
| Q2 2023 | $10,934,030 | -4.4% | 195,810 | -4.5% | 0.03% | -17.1% |
| Q1 2023 | $11,434,105 | -42.2% | 204,949 | -62.3% | 0.04% | -42.3% |
| Q4 2022 | $19,787,139 | +4210.9% | 543,006 | +17501.5% | 0.07% | +7000.0% |
| Q4 2021 | $459,000 | -93.9% | 3,085 | -94.1% | 0.00% | -96.3% |
| Q3 2021 | $7,584,000 | +44.1% | 52,094 | +93.8% | 0.03% | +42.1% |
| Q2 2021 | $5,263,000 | -44.8% | 26,879 | -49.0% | 0.02% | -54.8% |
| Q1 2021 | $9,537,000 | +14.9% | 52,693 | -10.1% | 0.04% | +16.7% |
| Q4 2020 | $8,300,000 | +19.2% | 58,617 | +5.0% | 0.04% | +33.3% |
| Q3 2020 | $6,961,000 | +22.7% | 55,833 | -12.1% | 0.03% | -6.9% |
| Q2 2020 | $5,674,000 | – | 63,535 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |